A shadow economy for unapproved slimming drugs is propelled by social media fitness personalities and sellers on communication apps, according to new investigations.
Investigational Treatment Gaining Traction Via Social Media
The experimental drug, which remains in clinical trials, is being advertised by online personalities for its supposed fat-burning properties. Followers are urged to message these accounts directly for source information, while also obtaining promotional offers.
Active Trade on Social Networks
Separately, a flourishing market exists on Telegram, where groups with thousands of participants share “before and after” photos, injection guides and claims of rapid British shipping. Vendors market the drug there before directing customers to WhatsApp for purchases.
Learning About Retatrutide
This medication is an experimental injection developed by US drugmaker Eli Lilly. The treatment affects three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies indicate it could assist individuals reduce up to a quarter of their total weight. Referred to as the “triple G”, the substance is being hailed digitally as the successor to Ozempic.
Medical Experts Voice Worries
However, doctors and chemists have warned that the distribution of what remains an unapproved drug in the UK is a cause for concern and could result in individuals injecting substances of unknown origin.
Several professionals stated the demand for retatrutide could be connected to the increasing cost of approved slimming products such as Mounjaro.
Legal Status and Enforcement
Marketing the unapproved drug on TikTok or Telegram is illegal in the United Kingdom, as it is an unlicensed drug that must not be promoted or distributed for personal consumption under the British medical regulations.
Several influencers try to sidestep the rules by calling to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted substance, but advertising and supply can still violate medicines, advertising, and consumer regulations, risking penalties, legal action or prison.
Platform Response and Content Elimination
According to TikTok, the platform has taken down problematic material and banned related hashtags and query recommendations. The company stated it was committed to keeping the platform safe and allocating resources in enhancing enforcement strategies.
Online Marketplace Activities
Investigations also discovered communities with up to 9,000 participants selling retatrutide using the platform's integrated discovery tool, which operates like a public directory. Typing “retatrutide” immediately brings up groups with thousands of members, populated with photos of weight loss, positive reviews and detailed instructions for mixing or administering at home.
Within minutes of joining one community, a seller shared contact information, where the majority of transactions occur. The vendor sent an guidebook and guaranteed shipping within 48 hours. When questioned whether the substance was authentic, one vendor responded: “You can’t be sure.” Another provided a photo of a supposed laboratory certificate. None inquired about weight, health issues or previous experience.
Product Details and Pricing
Within these groups, posts display black plastic packages with Royal Mail labels, claiming to contain new batches. One message read: “It took eight of us to load them this morning.”
Customers can select between powder vials, mixed at home with sterile water, or ready-to-use injectors usually sold at 160 pounds for 20 milligrams. When questioned how long a injector should last, sellers give conflicting answers ranging from a few weeks to “depends on your body”.
Service Moderation and Safety Actions
A representative for Telegram said it regularly moderated harmful material on its platform including material that encouraged the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.
Medical Expert Warnings
“People are administering materials they can’t verify. Even if the science behind retatrutide is valid, these digital products may not include what they advertise,” said a pharmacy expert, the director of pharmaceutical services at a pharmacy service.
A medical professional of an online medical service connected the surge in demand to recent price rises for authorized slimming medications such as Mounjaro. “With prices increasing, individuals are using social media. But fake treatments are highly risky. You cannot know what’s inside or whether the conditions they were produced in was clean,” she explained.
Her staff has previously seen individuals harmed by self-injection from unconfirmed suppliers. “We recognize the frustration, but buying from Telegram or WhatsApp is gambling with your health,” said Wyllie. “These substances could be contaminated or incorrectly dosed.”
Producer Statement
A spokesperson from Eli Lilly stated retatrutide was in third stage clinical trials and had not been evaluated or authorized by any regulatory agency anywhere in the world. “Consequently at this time no one can sell [it] for human use,” they explained, noting that any product “misleadingly claiming itself as a Lilly investigational product not yet authorized … may expose patients to possibly significant medical dangers”.
